Drug firm Ajanta Pharma said its board has approved a share buyback plan of up to Rs 286-crore, wherein the drug maker will buy back shares at a maximum price of Rs 2,550 apiece.
from Companies https://ift.tt/3ewf6Ks
via IFTTT
from Companies https://ift.tt/3ewf6Ks
via IFTTT
Comments
Post a Comment